Continuing HIV risk in New York city injection drug users: The association of syringe source and syringe sharing

Substance Use and Misuse

Volumn 46, Issue 2-3, 2011, Pages 192-200

  Jenness, Samuel M ^a   Hagan, Holly ^b   Liu, Kai Lih ^a   Wendel, Travis ^c   Murrill, Christopher S ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

HIV; injection drug use; risk behavior; syringe exchange; syringe sharing

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; DRUG ABUSE; DRUG USE; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; RISK; STATISTICAL MODEL; SUBSTANCE ABUSE; SYRINGE; UNITED STATES;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DRUG USERS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; NEW YORK CITY; RISK; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 79951562937     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.521467     Document Type: Article

References (76)

1. Abdul-Quader, A.S., Heckathorn, D.D., McKnight, C., Bramson, H., Nemeth, C., Sabin, K., et al.(2006).Effectiveness of respondent-driven sampling for recruiting drug users in New York City: Findings from a pilot study.Journal of Urban Health, 83(3), 459-476. (Pubitemid 44341557)
2. Bluthenthal, R., Malik, M.R., Grau, L.E., Singer, M., Marshall, P., & Heimer, R.(2004).Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.Addiction, 99(9), 1136-1146. (Pubitemid 39215275)
3. Bluthenthal, R., Ridgeway, G., Schell, T., Anderson, R., Flynn, N., & Kral, A.(2007).Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.Addiction, 102(4), 638-646. (Pubitemid 46398835)
4. Bluthenthal, R.N., Kral, A.H., Gee, L., Erringer, E.A., & Edlin, B.R.(2000).The effect of syringe exchange use on high-risk injection drug users: A cohort study.AIDS, 14(5), 605-611. (Pubitemid 30209702)
5. Bluthenthal, R.N., Kral, A.H., Lorvick, J., &Watters, J.K.(1997).Impact of law enforcement on syringe exchange programs: A look at Oakland and San Francisco.Medical Anthropology, 18(1), 61-83. (Pubitemid 127822119)
6. Brogly, S.B., Bruneau, J., Vincelette, J., Lamothe, F., & Franco, E.L.(2000).Risk behaviour change and HIV infection among injection drug users in Montreal.AIDS, 14(16), 2575-2582.
7. Centers for Disease Control and Prevention.(2007).Syringe exchange programs-United States, 2005.MMWR.Morbidity and Mortality Weekly Report, 56(44), 1164-1167.
8. Clatts, M.C., Goldsamt, L., Neaigus, A., & Welle, D.L.(2003).The social course of drug injection and sexual activity among YMSM and other high-risk youth: An agenda for future research.Journal of Urban Health, 80(4 Suppl.3), iii26-iii39.
9. Coffin, P.(2000).Syringe availability as HIV prevention: A review of modalities.Journal of Urban Health, 77(3), 306-330. (Pubitemid 30662040)
10. Cooper, H., Moore, L., Gruskin, S., & Krieger, N.(2005).The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study.Social Science & Medicine, 61(3), 673-684. (Pubitemid 40724611)
11. Cotten-Oldenburg, N.U., Carr, P., DeBoer, J.M., Collison, E.K., & Novotny, G.(2001).Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.Journal of Acquired Immune Deficiency Syndromes, 27(2), 183-192. (Pubitemid 32595170)
12. Coyle, S.L., Needle, R.H., & Normand, J.(1998).Outreach-based HIV prevention for injecting drug users: A review of published outcome data.Public Health Reports, 113(Suppl.1), 19-30. (Pubitemid 29330143)
13. Cunningham, C.O., Sohler, N.L., Berg, K.M., Shapiro, S., & Heller, D.(2006).Type of substance use and access to HIV-related health care.AIDS Patient Care and STDs, 20(6), 399-407. (Pubitemid 43993094)
14. Davis, C.S., Burris, S., Kraut-Becher, J., Lynch, K.G., & Metzger, D.(2005).Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA.American Journal of Public Health, 95(2), 233-236. (Pubitemid 40179818)
15. De, P., Cox, J., Boivin, J.F., Platt, R.W., & Jolly, A.M.(2007).Rethinking approaches to risk reduction for injection drug users: Differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.Journal of Acquired Immune Deficiency Syndromes, 46(3), 355-361. (Pubitemid 350287366)
16. Deren, S., Cleland, C.M., Fuller, C.M., Kang, S.Y., Des Jarlais, D.C., & Vlahov, D.(2006).The impact of syringe deregulation on sources of syringes for injection drug users: Preliminary findings.AIDS and Behavior, 10(6), 717-721. (Pubitemid 44627821)
17. Des Jarlais, D.C., Braine, N., & Friedmann, P.(2007).Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs.AIDS and Behavior, 11(6 Suppl.), 78-84.
18. Des Jarlais, D.C., Braine, N., Huso, Y., & Turner, C.(2007b).Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.AIDS Education and Prevention, 19(2), 111-123. (Pubitemid 46631751)
19. Des Jarlais, D.C., Hagan, H., Arasteh, K., McKnight, C., Perlman, D., & Friedman, S.R.(2007c).Herpes simplex virus-2 and HIV among noninjecting drug users in New York city.Sexually Transmitted Diseases, 34(11), 923-927. (Pubitemid 350287509)
20. Des Jarlais, D.C., Kamyar, A., Perlis, T., Hagan, H., Abdul-Quader, A., Heckathorn, D., et al.(2007d).Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.AIDS, 21, 231-235. (Pubitemid 46036932)
21. Des Jarlais, D.C., McKnight, C., & Friedmann, P.(2002).Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.Journal of the American Pharmaceutical Association (Washington, D.C.), 42(6 Suppl.2), S73-S76.
22. Des Jarlais, D.C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., et al.(2004)."Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.Journal of Acquired Immune Deficiency Syndromes, 35(2), 158-166. (Pubitemid 38133740)
23. Des Jarlais, D.C., Perlis, T., Arasteh, K., Torian, L.V., Beatrice, S., Milliken, J., et al.(2005).HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services.American Journal of Public Health, 95(8), 1439-1444. (Pubitemid 41060542)
24. Des Jarlais, D.C., Perlis, T., Friedman, S.R., Chapman, T., Kwok, J., Rockwell, R., et al.(2000).Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990-1997.American Journal of Public Health, 90(7), 1112-1116. (Pubitemid 30445366)
25. Des Jarlais, D.C., Perlis, T., Friedman, S.R., Deren, S., Chapman, T., Sotheran, J.L., et al.(1998).Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996.American Journal of Public Health, 88(12), 1801-1806. (Pubitemid 29017995)
26. Friedman, S.R., Cooper, H.L., Tempalski, B.,Keem,M., Friedman, R., Flom, P.L., et al.(2006).Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.AIDS, 20(1), 93-99. (Pubitemid 41818119)
27. Friedman, S.R., Lieb, S., Tempalski, B., Cooper, H., Keem, M., Friedman, R., et al.(2005).HIV among injection drug users in large US metropolitan areas, 1998.Journal of Urban Health, 82(3), 434-445. (Pubitemid 41191562)
28. Friedman, S.R., Tempalski, B., Cooper, H., Perlis, T., Keem, M., Friedman, R., et al.(2004).Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users.Journal of Urban Health, 81(3), 377-400. (Pubitemid 39128276)
29. Fuller, C.M., Galea, S., Blaney, S., Ompad, D.C., Deren, S., Des Jarlais, D.C., et al.(2004).Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.Ethnicity & Disease, 14(4), 589-596. (Pubitemid 39445582)
30. Fuller, C.M., Galea, S., Caceres, W., Blaney, S., Sisco, S., & Vlahov, D.(2007).Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.American Journal of Public Health, 97(1), 117-124. (Pubitemid 46067693)
31. Fuller, C.M., Vlahov, D., Latkin, C.A., Ompad, D.C., Celentano, D.D., & Strathdee, S.A.(2003).Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users.Journal of Acquired Immune Deficiency Syndromes, 32(1), 86-93. (Pubitemid 36091490)
32. Gallagher, K.M., Sullivan, P.S., Lansky, A., & Onorato, I.M.(2007).Behavioral surveillance among people at risk for HIV infection in the U.S.: The National HIV Behavioral Surveillance System.Public Health Reports, 122(Suppl.1), 32-38. (Pubitemid 47450427)
33. Golub, E.T., Strathdee, S.A., Bailey, S.L., Hagan, H., Latka, M.H., Hudson, S.M., et al.(2007).Distributive syringe sharing among young adult injection drug users in five U.S.cities.Drug and Alcohol Dependence, 91(Suppl.1), S30-S38. (Pubitemid 47451666)
34. Hagan, H., Campbell, J.V., Thiede, H., Strathdee, S.A., Ouellet, L.J., Latka,M.H., et al.(2007).Injecting alone among young adult IDUs in five US cities: Evidence of low rates of injection risk behavior.Drug and Alcohol Dependence, 91(Suppl.1), S48-S55. (Pubitemid 47470020)
35. Heckathorn, D.(1997).Respondent-driven sampling: A new approach to the study of hidden populations.Social Problems, 44(2), 174-199.
36. Heckathorn, D.(2002).Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations.Social Problems, 49(1), 11-34.
37. Heckathorn, D.(2007).Extensions of respondent-driven sampling: Analyzing continuous variables and controlling for differential recruitment.Sociological Methodology, 37(1), 151-207.
38. Heimer, R.(2005).Critical issues and further questions about respondent-driven sampling: Comment on Ramirez-Valles, et al.(2005).AIDS and Behavior, 9(4), 403-408; discussion 409-413.
39. Hennessy, R.R., Weisfuse, I.B., & Schlanger, K.(2007).Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care? Public Health Reports, 122(Suppl.2), 31-35. (Pubitemid 47443828)
40. Huo, D., & Ouellet, L.J.(2007).Needle exchange and injectionrelated risk behaviors in Chicago: A longitudinal study.Journal of Acquired Immune Deficiency Syndromes, 45(1), 108-114. (Pubitemid 46684450)
41. Kang, S.Y., Deren, S., Andia, J., Colon, H.M., Robles, R., & Oliver-Velez, D.(2005).HIV transmission behaviors in jail/prison among Puerto Rican drug injectors in New York and Puerto Rico.AIDS and Behavior, 9(3), 377-386. (Pubitemid 41584989)
42. Kellerman, S.E., Drake, A., Lansky, A., & Klevens, R.M.(2006).Use of and exposure to HIV prevention programs and services by persons at high risk for HIV.AIDS Patient Care and STDs, 20(6), 391-398. (Pubitemid 43993093)
43. Kershaw, S.(2008).New HIV cases drop but rise in young gaymen.New York Times, A24.
44. Ksobiech, K.(2003).A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders.AIDS Education and Prevention, 15(3), 257-268. (Pubitemid 36791290)
45. Ksobiech, K.(2004).Assessing and improving needle exchange programs: Gaps and problems in the literature.Harm Reduction Journal, 1(4), 1-7.
46. Lansky, A., Abdul-Quader, A.S., Cribbin, M., Hall, T., Finlayson, T.J., Garfein, R.S., et al.(2007).Developing an HIV behavioral surveillance system for injecting drug users: The National HIV Behavioral Surveillance System.Public Health Reports, 122(Suppl.1), 48-55. (Pubitemid 47450429)
47. Lansky, A., Sullivan, P.S., Gallagher, K.M., & Fleming, P.L.(2007).HIV behavioral surveillance in the U.S.: A conceptual framework.Public Health Reports, 122(Suppl.1), 16-23. (Pubitemid 47450425)
48. Lorvick, J., Bluthenthal, R.N., Scott, A., Gilbert, M.L., Riehman, K.S., Anderson, R.L., et al.(2006).Secondary syringe exchange among users of 23 California syringe exchange programs.Substance Use & Misuse, 41(6-7), 865-882. (Pubitemid 43995137)
49. Lurie, P., Jones, T.S., & Foley, J.(1998).A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl.1), S45-S51. (Pubitemid 28304468)
50. Magnani, R., Sabin, K., Saidel, T., & Heckathorn, D.(2005).Review of sampling hard-to-reach and hidden populations for HIV surveillance.AIDS, 19(Suppl.2), S67-S72.
51. Masson, C., Sorensen, J., Perlman, D., Shopshire,M., Delucchi, K., TeChieh, C., et al.(2007).Hospital- versus community-based syringe exchange: A randomized controlled trial.AIDS Education and Prevention, 19(2), 97-110. (Pubitemid 46631750)
52. Metsch, L.R., Pereyra, M., Purcell, D.W., Latkin, C.A., Malow, R., Gomez, C.A., et al.(2007).Correlates of lending needles/ syringes among HIV-seropositive injection drug users.Journal of Acquired Immune Deficiency Syndromes, 46(Suppl.2), S72-S79. (Pubitemid 350293783)
53. Metzger, D.S., & Navaline, H.(2003).HIV prevention among injection drug users: The need for integrated models.Journal of Urban Health, 4(Suppl.3), iii59-iii66.
54. Novelli, L.A., Sherman, S.G., Havens, J.R., Strathdee, S.A., & Sapun, M.(2005).Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.Drug and Alcohol Dependence, 77(3), 303-309. (Pubitemid 40283532)
55. O'Connell, J.M., Kerr, T., Li, K., Tyndall, M.W., Hogg, R.S., Montaner, J.S., et al.(2005).Requiring help injecting independently predicts incident HIV infection among injection drug users.Journal of Acquired Immune Deficiency Syndromes, 40(1), 83-88. (Pubitemid 41233210)
56. Osmond, D.H., Pollack, L.M., Paul, J.P., & Catania, J.A.(2007).Changes in prevalence of HIV infection and sexual risk behavior in men who have sex with men in San Francisco: 1997-2002.American Journal of Public Health, 97(9), 1677-1683. (Pubitemid 351182334)
57. Porter, J., Metzger, D.,&Scotti, R.(2002).Bridge to services: Drug injectors' awareness and utilization of drug user treatment and social service referrals, medical care, and HIV testing provided by needle exchange programs.Substance Use &Misuse, 37(11), 1305-1330.
58. Pouget, E.R., Deren, S., Fuller, C.M., Blaney, S., McMahon, J.M., Kang, S.Y., et al.(2005).Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.Journal of Acquired Immune Deficiency Syndromes, 39(4), 471-477. (Pubitemid 41003795)
59. Reich, W., Compton, W.M., Horton, J.C., Cottler, L.B., Cunningham-Williams, R.M., Booth, R., et al.(2002).Injection drug users report good access to pharmacy sale of syringes.Journal of the American Pharmaceutical Association (Washington, D.C.), 42(6 Suppl.2), S68-S72.
60. Rhodes, T., Judd, A., Mikhailova, L., Sarang, A., Khutorskoy, M., Platt, L., et al.(2004).Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: Maximizing the protective effects of syringe distribution.Journal of Acquired Immune Deficiency Syndromes, 35(3), 293-300. (Pubitemid 38280656)
61. Rhodes, T., Mikhailova, L., Sarang, A., Lowndes, C.M., Rylkov, A., Khutorskoy,M., et al.(2003).Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment.Social Science & Medicine, 57(1), 39-54. (Pubitemid 36566517)
62. Rich, J.D., Strong, L., Towe, C.W., & McKenzie, M.(1999).Obstacles to needle exchange participation in Rhode Island.Journal of Acquired Immune Deficiency Syndromes, 21(5), 396-400. (Pubitemid 29384001)
63. Rockwell, R., Deren, S., Goldstein, M.F., Friedman, S.R., & Des Jarlais, D.C.(2002).Trends in the AIDS epidemic among New York City's injection drug users: Localized or citywide? Journal of Urban Health, 79(1), 136-146. (Pubitemid 34478029)
64. Rothman, J., Rudnick, D., Slifer, M., Agins, B., Heiner, K., & Birkhead, G.(2007).Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: A model for effective service delivery to a high-risk population.Journal of Urban Health, 84(2), 226-242. (Pubitemid 46425398)
65. Rothman, K.J., & Greenland, S.(1998).Modern epidemiology. Philadelphia: Lippincott Williams.
66. Salganik, M.J.(2006).Variance estimation, design effects, and sample size calculations for respondent-driven sampling.Journal of Urban Health, 83(6 Suppl.), 98-112.
67. Sanchez, T., Finlayson, T., Drake, A., Behel, S., Cribbin, M., Dinenno, E., et al.(2006).Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors-United States, National HIV Behavioral Surveillance System: Men who have sex with men, November 2003-April 2005.MMWR.Surveillance Summaries, 55(6), 1-16.
68. Santibanez, S.S., Garfein, R.S., Swartzendruber, A., Purcell, D.W., Paxton, L.A., & Greenberg, A.E.(2006).Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.Journal of Urban Health, 83(1), 86-100. (Pubitemid 44337045)
69. SAS Institute, Inc.(2005).Design and analysis of probability surveys.Cary, NC: SAS Institute.
70. Somlai, A.M., Kelly, J.A., McAuliffe, T.L., Ksobiech, K., & Hackl, K.L.(2003).Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women.AIDS and Behavior, 7(4), 383-393. (Pubitemid 38005001)
71. Taussig, J.A., Weinstein, B., Burris, S., & Jones, T.S.(2000).Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.AIDS, 14(Suppl.1), S47-S51.
72. Tempalski, B., Flom, P., Friedman, S.R., Des Jarlais, D.C., Friedman, J., McKnight, C., et al.(2007).Social and political factors predicting the presence of syringe exchange programs in 96 U.S.metropolitan areas.American Journal of Public Health, 97(3), 437-447. (Pubitemid 47280192)
73. Thiede, H., Hagan, H., Campbell, J.V., Strathdee, S.A., Bailey, S.L., Hudson, S.M., et al.(2007).Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S.cities.Drug and Alcohol Dependence, 91(Suppl.1), S39-S47. (Pubitemid 47470022)
74. Tortu, S., McMahon, J.M., Hamid, R., & Neaigus, A.(2003).Women's drug injection practices in East Harlem: An event analysis in a high-risk community.AIDS and Behavior, 7(3), 317-328. (Pubitemid 37203918)
75. van Ameijden, E.J., Krol, A., Vlahov, D., Flynn, C., van Haastrecht, H.J., & Coutinho, R.A.(1999).Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: An ecological comparison.Substance Use&Misuse, 34(6), 845-865. (Pubitemid 29202716)
76. Vlahov, D., Des Jarlais, D.C., Goosby, E., Hollinger, P.C., Lurie, P.G., Shriver, M.D., et al.(2001).Needle exchange programs for the prevention of human immunodeficiency virus infection: Epidemiology and policy.American Journal of Epidemiology, 154(12 Suppl.), S70-S77. (Pubitemid 33144494)